RxDoctor Payments Data

Stacey Murray

Nurse Practitioner · Foxboro, MANPI 1467633743

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $8,354 of the $12,591 with a category attached, or 66.3%. Biogen accounts for 62.6% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2021 at $11,858 and has fallen 99.9% since, to $16 in 2025. Among nurse practitioner clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,591in general payments, 2019–2025

Across 159 payments — averaging $79.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$8K
  • Bristol Myers Squibb$1K
  • E.r. Squibb & Sons, L.L.C.$1K
  • EMD Serono, Inc.$376
  • Lundbeck LLC$198
  • Biohaven Pharmaceuticals, Inc.$193
  • plus $2K from 29 others

What the payments were for

  • Consulting fees$1,20610%
  • Speaking & faculty fees$8,35466%
  • Food & beverage$2,86823%
  • Education$1631%

General payments by program year

21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,591 in reported general payments places this provider in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.

See all nurse practitioner providers in Massachusetts

Other nurse practitioner in Foxboro

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →